wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33428645-0C5A6AA9-2118-4BDD-940B-D3A6E8F9FD35
Q33428645-0C5A6AA9-2118-4BDD-940B-D3A6E8F9FD35
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33428645-0C5A6AA9-2118-4BDD-940B-D3A6E8F9FD35
Phase 2 trial of neoadjuvant bevacizumab plus pemetrexed and carboplatin in patients with unresectable stage III lung adenocarcinoma (GASTO 1001).
P2860
Q33428645-0C5A6AA9-2118-4BDD-940B-D3A6E8F9FD35
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33428645-0C5A6AA9-2118-4BDD-940B-D3A6E8F9FD35
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
7523473d836e0061e845ae86c1b578803cb563fb
P2860
Randomized, double-blinded, multicenter, phase II study of pemetrexed, carboplatin, and bevacizumab with enzastaurin or placebo in chemonaïve patients with stage IIIB/IV non-small cell lung cancer: Hoosier Oncology Group LUN06-116.